ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
도네페질 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 연평균 복합 성장률(CAGR) 4.5%를 나타내 12억 4,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 의료비 증가, 알츠하이머병의 조기 진단에 대한 주목 증가, 병용 요법에 대한 수요 증가, 헬스케어 인프라에 대한 투자 증가, 신경퇴행성 질환에 대한 의식 증가 등에 기인하고 있습니다. 예측 기간의 주요 동향으로는 제제 및 전달방법의 혁신, 기술의 진보, 신규제형과 제제의 발매, 도네페질의 제네릭 의약품의 승인, 첨단 연구시설 등을 들 수 있습니다.
향후 5년간의 성장률을 4.5%를 나타내 예측한 것은 동 시장의 전회 예측으로부터 0.3%의 소폭의 감소를 반영한 것입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 인상은 중국과 한국에서 조달하는 도네페질 염산염 정제의 비용을 밀어 올리고, 알츠하이머병의 치료비를 악화시켜, 인지장애의 관리 부담을 증가시킴으로써, 미국의 메모리 클리닉에 부담을 줄 가능성이 높습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
알츠하이머병의 유병률 증가는 도네페질 시장 성장을 가속할 것으로 예측됩니다. 알츠하이머병은 진행성 신경질환으로, 뇌세포의 변성과 사멸을 일으키고, 기억 상실, 인지 기능의 저하, 행동의 변화를 초래합니다. 알츠하이머병 환자 증가는 노화, 인구 증가, 라이프스타일 관련 위험, 만성 질환 증가, 유전적 소인, 환경 노출 등의 요인에 기인합니다. 도네페질은 뇌의 아세틸콜린 농도에 영향을 주어 인지 기능과 일상생활 능력을 향상시키고 알츠하이머병의 증상을 관리하는데 중요한 역할을 하고 있습니다. 예를 들어, 2024년 5월 알츠하이머병 치료, 지원, 연구를 전문으로 하는 미국 비영리 단체인 알츠하이머병 협회의 보고에 따르면 알츠하이머형 치매로 진단된 65세 이상의 미국인 수는 2022년 650만명에서 2024년에는 690만명으로 증가했다고 합니다. 그 결과, 알츠하이머병의 이환율 상승이 도네페질 시장 확대에 박차를 가하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 도네페질 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 도네페질 시장 : 성장률 분석
세계의 도네페질 시장 실적 : 규모와 성장(2019-2024년)
세계의 도네페질 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 도네페질 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 도네페질 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
5mg
10mg
23mg
세계의 도네페질 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
경피
세계의 도네페질 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
약국
세계의 도네페질 시장 : 5mg 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
즉효형 5mg
구강분해형 5mg
세계의 도네페질 시장 : 10mg 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
즉효형 10mg
구강분해형 10mg
세계의 도네페질 시장 : 23mg 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
서방형 23mg
필름 코팅 23mg
제7장 지역별/국가별 분석
세계의 도네페질 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 도네페질 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
도네페질 시장 : 경쟁 구도
도네페질 시장 : 기업 프로파일
AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Teva Pharmaceutical Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Intas Pharmaceuticals Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Mylan NV : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sandoz Group AG
Hetero Drugs Ltd.
Sun Pharmaceutical Inc.
Eisai Co. Ltd.
Cipla Ltd.
Dr Reddy's Laboratories
Apotex Inc.
H Lundbeck A/S
Zydus Cadila
Amneal Pharmaceuticals LLC
Torrent Pharmaceuticals Ltd
Alkem Laboratories Ltd.
Jubilant Pharmova Ltd.
Wockhardt Ltd.
Luoxin Pharmaceuticals Group
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
도네페질 시장(2029년) : 새로운 기회를 제공하는 국가
도네페질 시장(2029년) : 새로운 기회를 제공하는 부문
도네페질 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Donepezil is a medication used to manage symptoms of Alzheimer's disease by preventing the breakdown of acetylcholine, a neurotransmitter essential for memory and cognition. As a cholinesterase inhibitor, it enhances cognitive function and helps slow symptom progression in patients with mild to moderate Alzheimer's disease.
The primary dosage forms of donepezil include 5 mg, 10 mg, and 23 mg. The 5 mg dosage specifically refers to donepezil hydrochloride, commonly prescribed for treating dementia associated with Alzheimer's disease. It is administered through various routes, such as oral and transdermal, and is utilized across multiple settings, including hospitals, clinics, and drugstores.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.
The donepezil market research report is one of a series of new reports from The Business Research Company that includes donepezil market statistics, including donepezil industry global market size, regional shares, competitors with a donepezil market share, detailed donepezil market segments, market trends and opportunities, and any further data you may need to thrive in the donepezil industry. This donepezil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The donepezil market size has grown steadily in recent years. It will grow from $1 billion in 2024 to $1.04 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to the increasing prevalence of Alzheimer's disease, the growing geriatric population, the rise in government spending and programs, the rising awareness of neurodegenerative disorders, and the rise in demand for high-quality nucleic acid samples.
The donepezil market size is expected to see steady growth in the next few years. It will grow to $1.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to rising healthcare expenditure, increasing focus on early diagnosis of Alzheimer's, growing demand for combination therapies, growing investment in healthcare infrastructure, and growing consciousness about neurodegenerative illnesses. Major trends in the forecast period include innovations in drug formulations and delivery methods, technological advancements, the launch of novel dosage forms and formulations, the approval of generic versions of donepezil, and advanced research facilities.
The forecast of 4.5% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. memory clinics by driving up costs of donepezil hydrochloride tablets sourced from China and South Korea, exacerbating Alzheimer's disease treatment expenses and increasing cognitive disorder management burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of Alzheimer's disease is expected to drive the growth of the donepezil market. Alzheimer's disease is a progressive neurological disorder that leads to brain cell degeneration and death, resulting in memory loss, cognitive decline, and behavioral changes. The rise in Alzheimer's cases is attributed to factors such as an aging population, population growth, lifestyle-related risks, the increase in chronic diseases, genetic predisposition, and environmental exposures. Donepezil plays a crucial role in managing Alzheimer's symptoms by improving cognitive function and daily living abilities through its effect on acetylcholine levels in the brain. For instance, in May 2024, a report by the Alzheimer's Association, a US-based nonprofit dedicated to Alzheimer's care, support, and research, indicated that the number of Americans aged 65 and older diagnosed with Alzheimer's dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising incidence of Alzheimer's disease is fueling the expansion of the donepezil market.
Leading companies in the donepezil market are focusing on developing innovative technologies such as advanced transdermal systems to enhance patient compliance and treatment effectiveness through extended-release formulations. The donepezil system refers to the pharmacological mechanism of action of donepezil, a medication primarily used for treating Alzheimer's disease and other forms of dementia. For instance, in October 2022, Corium Innovation Inc., a US-based biopharmaceutical company, launched the donepezil transdermal system (Adlarity) for treating patients with mild, moderate, or severe Alzheimer's disease dementia. This transdermal formulation delivers donepezil directly through the skin, bypassing the digestive system, thereby reducing gastrointestinal side effects and offering a more convenient administration method. This innovation benefits both Alzheimer's patients and their caregivers by improving adherence to treatment.
In August 2023, Corium Innovation Inc. partnered with Lotus Pharmaceuticals to expand the availability of ADLARITY(R) in multiple Asian markets. The partnership includes a license agreement for ADLARITY, an innovative donepezil transdermal system for treating Alzheimer's dementia, across ten markets in Asia. Lotus Pharmaceuticals, a Taiwan-based pharmaceutical company, specializes in commercializing both novel and generic pharmaceuticals, helping to bring advanced Alzheimer's treatments to a broader global population.
Major players in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy's Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group.
North America was the largest region in the donepezil market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in donepezil report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the donepezil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The donepezil market consists of sales of orally disintegrating tablets, experimental and niche products, active pharmaceutical ingredients, and combination medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Donepezil Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on donepezil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for donepezil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The donepezil market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: 5mg; 10mg; 23mg
2) By Route Of Administration: Oral; Transdermal
3) By Application: Hospitals; Clinics; Drugstore
Subsegments:
1) By 5mg: Immediate-Release 5mg; Orally Disintegrating 5mg
2) By 10mg: Immediate-Release 10mg; Orally Disintegrating 10mg
3) By 23mg: Extended-Release 23mg; Film-Coated 23mg
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Donepezil Market Characteristics
3. Donepezil Market Trends And Strategies
4. Donepezil Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Donepezil Growth Analysis And Strategic Analysis Framework
5.1. Global Donepezil PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Donepezil Market Growth Rate Analysis
5.4. Global Donepezil Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Donepezil Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Donepezil Total Addressable Market (TAM)
6. Donepezil Market Segmentation
6.1. Global Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
5mg
10mg
23mg
6.2. Global Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Transdermal
6.3. Global Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Drugstore
6.4. Global Donepezil Market, Sub-Segmentation Of 5mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release 5mg
Orally Disintegrating 5mg
6.5. Global Donepezil Market, Sub-Segmentation Of 10mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immediate-Release 10mg
Orally Disintegrating 10mg
6.6. Global Donepezil Market, Sub-Segmentation Of 23mg, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Extended-Release 23mg
Film-Coated 23mg
7. Donepezil Market Regional And Country Analysis
7.1. Global Donepezil Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Donepezil Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Donepezil Market
8.1. Asia-Pacific Donepezil Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Donepezil Market
9.1. China Donepezil Market Overview
9.2. China Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Donepezil Market
10.1. India Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Donepezil Market
11.1. Japan Donepezil Market Overview
11.2. Japan Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Donepezil Market
12.1. Australia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Donepezil Market
13.1. Indonesia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Donepezil Market
14.1. South Korea Donepezil Market Overview
14.2. South Korea Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Donepezil Market
15.1. Western Europe Donepezil Market Overview
15.2. Western Europe Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Donepezil Market
16.1. UK Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Donepezil Market
17.1. Germany Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Donepezil Market
18.1. France Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Donepezil Market
19.1. Italy Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Donepezil Market
20.1. Spain Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Donepezil Market
21.1. Eastern Europe Donepezil Market Overview
21.2. Eastern Europe Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Donepezil Market
22.1. Russia Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Donepezil Market
23.1. North America Donepezil Market Overview
23.2. North America Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Donepezil Market
24.1. USA Donepezil Market Overview
24.2. USA Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Donepezil Market
25.1. Canada Donepezil Market Overview
25.2. Canada Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Donepezil Market
26.1. South America Donepezil Market Overview
26.2. South America Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Donepezil Market
27.1. Brazil Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Donepezil Market
28.1. Middle East Donepezil Market Overview
28.2. Middle East Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Donepezil Market
29.1. Africa Donepezil Market Overview
29.2. Africa Donepezil Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Donepezil Market, Segmentation By Route Of Administeration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Donepezil Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Donepezil Market Competitive Landscape And Company Profiles
30.1. Donepezil Market Competitive Landscape
30.2. Donepezil Market Company Profiles
30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Teva Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Mylan NV Overview, Products and Services, Strategy and Financial Analysis
31. Donepezil Market Other Major And Innovative Companies
31.1. Sandoz Group AG
31.2. Hetero Drugs Ltd.
31.3. Sun Pharmaceutical Inc.
31.4. Eisai Co. Ltd.
31.5. Cipla Ltd.
31.6. Dr Reddy's Laboratories
31.7. Apotex Inc.
31.8. H Lundbeck A/S
31.9. Zydus Cadila
31.10. Amneal Pharmaceuticals LLC
31.11. Torrent Pharmaceuticals Ltd
31.12. Alkem Laboratories Ltd.
31.13. Jubilant Pharmova Ltd.
31.14. Wockhardt Ltd.
31.15. Luoxin Pharmaceuticals Group
32. Global Donepezil Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Donepezil Market
34. Recent Developments In The Donepezil Market
35. Donepezil Market High Potential Countries, Segments and Strategies
35.1 Donepezil Market In 2029 - Countries Offering Most New Opportunities
35.2 Donepezil Market In 2029 - Segments Offering Most New Opportunities
